Enanta Pharmaceuticals(DE:9EP)
€7.450.00 (-3.87%)
DE:9EP
Enanta Pharmaceuticals earnings date
€7.45
At close:0.00 (-3.87%)
Enanta Pharmaceuticals (9EP) Q4 2024 Earnings Report
0 Followers
DE:9EP Q4 2024 EPS Results
- Actual EPS
- -EUR 1.24
- Consensus EPS
- -EUR 1.06
- Beat/Miss
- Missed by -EUR 0.18
- One Year Ago EPS
- -EUR 1.21
DE:9EP Q4 2024 Revenue Results
- Actual Revenue
- EUR 13.31M
- Expected Revenue
- EUR 16.34M
- Beat/Miss
- Missed by -EUR 3.03M
- YoY Revenue Growth
- -22.84%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 11/25/2024
- Time
- After Close
- Conference Call
- Monday, November 25, 2024
DE:9EP Upcoming Earnings
Enanta Pharmaceuticals's next earnings date is estimated for February 8, 2027, based on past reporting schedules.
Q4 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:9EP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 08, 2027 | 2027 (Q1) | -0.57- | -0.38 | ― | ― |
| Nov 16, 2026 | 2026 (Q4) | -0.66-0.74 | -0.79 | 6.90% (+0.05) | |
| Aug 10, 2026 | 2026 (Q3) | -0.46-0.61 | -0.77 | 21.18% (+0.16) | |
| May 11, 2026 | 2026 (Q2) | -0.44-0.41 | -0.97 | 57.55% (+0.56) | |
| Feb 09, 2026 | 2026 (Q1) | -0.70-0.38 | -0.96 | 60.00% (+0.57) | |
| Nov 17, 2025 | 2025 (Q4) | -0.93-0.79 | -1.24 | 36.03% (+0.45) | |
| Aug 11, 2025 | 2025 (Q3) | -0.82-0.77 | -0.98 | 20.56% (+0.20) | |
| May 12, 2025 | 2025 (Q2) | -1.05-0.97 | -1.34 | 27.89% (+0.37) | |
| Feb 10, 2025 | 2025 (Q1) | -1.23-0.96 | -1.44 | 33.54% (+0.48) | |
| Nov 25, 2024 | 2024 (Q4) | -1.06-1.24 | -1.21 | -2.26% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

